Binding Site Offers Antibody/Antigen Products with Emphasis on Human Complement & Coagulation Applications

Binding Site announces a major expansion to their antibody and antigen product offerings for human coagulation and complement applications

Written byBinding Site
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00

lifescience-bindingsite-coagulationBinding Site’s Immunologicals Group is pleased announce that it has just completed a major expansion to their antibody and antigen product offerings for human Coagulation and Complement applications. Both Prothombin and Glycerol-Free Prothombin proteins are available as antigens, while the antibody products include, but are not limited, to Anti-Human C1; C3; C4; C5; C8; Factor H; Factor I; Fibrinogen; Fibronectin; Plasminogen; Prothombin; Thrombin; and von Willebrand Factor. Availability of these products will enhance the needs of IVD manufacturers, along with biopharmaceutical, clinical, and life science researchers, as all of the products are designed to work as critical components within a number of enzyme immunoassay applications, especially ELISA.  

The available antigens exhibit exceptional purity levels as a result of unique chromatographic techniques, while the antibodies demonstrate outstanding degrees of both purity and specificity. Both product lines feature extended shelf-life stability claims and lot-to-lot consistencies. All are available in unitized, standard-vial size formats, with bulk packaging and customer-specific fabrication options available as well.

Binding Site’s Immunologicals Group serves the in-vitro diagnostic (IVD) manufacturing and clinical/life-science research markets with a comprehensive line of innovative products. For additional information, contact The Binding Site, Inc. at 6730 Mesa Ridge Road, San Diego, CA 92121 USA. Phone: 800-633-4484; FAX: 858-453-9189; Email: info@thebindingsite.com. Please visit our website at www.thebindingsite.com

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - October 2025

Turning Safety Principles Into Daily Practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Lab Manager October 2025 Cover Image